Table 5.
Antimicrobial susceptibility patterns of GBS isolates from pregnant mothers and neonates.
| Antimicrobial | Disc potency (μg) | Susceptible, N (%) | Intermediate, N (%) | Resistant, N (%) |
|---|---|---|---|---|
| Ampicillin | 10 | 35 (100) | 0 | 0 |
| Penicillin | 10 | 35 (100) | 0 | 0 |
| Ceftriaxone | 30 | 35 (100) | 0 | 0 |
| Vancomycin | 30 | 35 (100) | 0 | 0 |
| Erythromycin | 15 | 24 (68.6) | 8 (23.0) | 3 (8.6) |
| Azithromycin | 15 | 35 (100) | (0) | 0 |
| Clarithromycin | 15 | 34 (97.1) | 1 (2.9) | 0 |
| Tetracycline | 30 | 29 (82.9) | 6 (17.1) | 0 |
| Chloramphenicol | 30 | 31 (88.6) | 3 (8.6) | 1 (2.9) |
| Clindamycin | 2 | 26 (74.3) | 7 (20.0) | 2 (5.7) |
| Ciprofloxacin | 5 | 35 (100) | 0 | 0 |